FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure.
52 
Let's personalize your content